Massachusetts Financial Services
KLRS

Massachusetts Financial Services’s Kalaris Therapeutics KLRS Stock Holding History

Massachusetts Financial Services’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,125
Closed -$1.79M – 875
2023
Q3 		$1.79M Sell
36,125
-7,837
-18% -$534K ﹤0.01% 731
2023
Q2 		$3.44M Sell
43,962
-551
-1% -$52.4K ﹤0.01% 667
2023
Q1 		$4.03M Buy
44,513
+1,876
+4% +$239K ﹤0.01% 658
2022
Q4 		$5.03M Buy
42,637
+6,299
+17% +$1.07M ﹤0.01% 655
2022
Q3 		$6.59M Buy
36,338
+2,461
+7% +$383K ﹤0.01% 639
2022
Q2 		$3.04M Sell
33,877
-254
-0.7% -$26.6K ﹤0.01% 683
2022
Q1 		$5.3M Buy
34,131
+943
+3% +$188K ﹤0.01% 671
2021
Q4 		$9.88M Sell
33,188
-245
-0.7% -$114K ﹤0.01% 662
2021
Q3 		$19.3M Buy
33,433
+6,844
+26% +$3.17M 0.01% 617
2021
Q2 		$12.1M Sell
26,589
-79
-0.3% -$40.8K ﹤0.01% 658
2021
Q1 		$14.4M Sell
26,668
-626
-2% -$526K ﹤0.01% 636
2020
Q4 		$24.1M Buy
27,294
+508
+2% +$391K 0.01% 572
2020
Q3 		$16.9M Buy
+26,786
New +$18.3M 0.01% 586

Other funds holding KLRS

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Massachusetts Financial Services's KLRS Position: Q4 2023 in Review

Massachusetts Financial Services sold out of Kalaris Therapeutics (KLRS) in Q4 2023, closing a stake of 36,125 shares — an estimated $1.79M sold.

Massachusetts Financial Services first reported a position in KLRS in Q3 2020 and held it in 13 quarters. The position peaked at $24.1M in Q4 2020. 81 funds tracked by Wall St. Rank hold KLRS as of Q4 2023.

  • Massachusetts Financial Services reported no remaining Kalaris Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Massachusetts Financial Services sold 36,125 Kalaris Therapeutics shares in Q4 2023, an estimated $1.79M.
  • Massachusetts Financial Services first reported a position in Kalaris Therapeutics in Q3 2020 and held it in 13 quarters.
  • Massachusetts Financial Services's Kalaris Therapeutics position peaked at $24.1M in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Kalaris Therapeutics as of Q4 2023.

Based on Massachusetts Financial Services's 13F filing for Q4 2023, filed 8 Feb 2024.